Schifanella, L., Barnett, S. W., Bissa, M., Galli, V., Doster, M. N., Vaccari, M., … Franchini, G. (2020). Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type. PLoS Pathog, 16(4), e1008531. https://doi.org/10.1371/journal.ppat.1008531

Schifanella, Luca, Susan W. Barnett, Massimiliano Bissa, Veronica Galli, Melvin N. Doster, Monica Vaccari, Georgia D. Tomaras, et al. “Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.” PLoS Pathog 16, no. 4 (April 2020): e1008531. https://doi.org/10.1371/journal.ppat.1008531.

Schifanella L, Barnett SW, Bissa M, Galli V, Doster MN, Vaccari M, et al. Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type. PLoS Pathog. 2020 Apr;16(4):e1008531.

Schifanella, Luca, et al. “Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.” PLoS Pathog, vol. 16, no. 4, Apr. 2020, p. e1008531. Pubmed, doi:10.1371/journal.ppat.1008531.

Schifanella L, Barnett SW, Bissa M, Galli V, Doster MN, Vaccari M, Tomaras GD, Shen X, Phogat S, Pal R, Montefiori DC, LaBranche CC, Rao M, Trinh HV, Washington-Parks R, Liyanage NPM, Gorini G, Brown DR, Liang F, Loré K, Venzon DJ, Magnanelli W, Metrinko M, Kramer J, Breed M, Alter G, Ruprecht RM, Franchini G. Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type. PLoS Pathog. 2020 Apr;16(4):e1008531.